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a  b  s  t  r  a  c  t
The  fetal  toxicities  of  multi-wall  carbon  nanotubes  (MWCNTs)  with  various  sizes were  compared  in
CD1(ICR)  mice.  MWCNTs  were  suspended  in  2% sodium  carboxymethyl  cellulose  solution  in phosphate-
buffered  saline.  On  day  9 of  gestation,  dams  were  administered  a single  intraperitoneal  dose  of  MWCNTs
(4 mg/kg  body  weight),  while  dams  in the  control  group  were  administered  vehicle  (10 mL/kg  body
weight).  The  rectal  temperatures  of the dams  were  monitored  2  h after  administaration  to  asses  sta-
tuses  of the  dams.  The  dams  and  fetuses  were  examined  on  day  18  of  gestation.  The  number  of live fetus
per  dam  decreased  in  some  MWCNTs-administered  groups.  The  mean  percentages  of  live  fetuses  in  total
implantations  in  the  MWCNTs-administered  groups  markedly  varied  from  0%  to 95%, and  the  highest
mean  percentage  of  live  fetuses  in  the  MWCNTs-administered  group  was  equivalent  to  that  of  the  con-
trol group.  The  decrease  in  live  fetuses  depended  on  an  increased  number  of  early  dead  fetuses.  In  theonocyte chemoattractant protein-1 groups  with  markedly  lowered  rectal temperature  after  administration,  the  fetal  loss  were  evident.  The
blood  levels  of interleukin-6  and/or  monocyte  chemoattractant  protein-1  in dam  2  h  after  administration
of  MWCNTs  markedlyr  increased,  especially  in  the  goups  with  signiﬁcant  decrease  in live  fetuses.  These
results  indicated  a relationship  between  inﬂammation  in the  dam,  which  probabely  depended  on  the
particular  length  of the  MWCNTs,  and the  fetal  toxicioty  of  MWCNTs  in  mice.
©  2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC. Introduction
Recently, rapidly developing nanotechnologies have produced
any kinds of nanomaterials that are appealing new resources that
ay  make our life more convenient. Critical risk assessments have
een conducted of the possible adverse effects of these materials
n order to ensure the safety of humans, and domestic and com-
anion animal. Among those, many investigators have paid close
ttention to carbon nanotubes, a very anticipated nanomaterial,
ecause the size and structure of carbon nanotubes resemble those
f asbestos [16,1,4,14,13,18,10]. First, Takagi et al. [19] reported the
nduction of mesotheliomas by the intraperitoneal administration
Abbreviations: MWCNTs, multi-wall carbon nanotubes; IL-6, interleukin-6;
CP-1, monocyte chemoattractant protein-1.
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of multi-wall carbon nanotubes (MWCNTs) to male p53-deﬁcient
mice. Subsequently, Sakamoto et al. [17] found the induction of
mesotheliomas by MWCNTs in intact (not genetically modiﬁed)
rats. In addition, during the course of various toxicological evalua-
tions of MWCNTs in our laboratory, we  revealed the teratogenicity
of MWCNTs that were intraperitoneally or intratracheally admin-
istered to mice [5]. Currently, MWCNTs are a focus of attention
in exogenous ﬁbrous toxicity [10,12,2,21], because both mesothe-
lioma and teratogenicity are induced by MWCNTs at lower dose
levels than those of asbestos that cause the same effects [17,5,6].
Difference abilities for inducing inﬂammation and formation of
mesothelial granulomas and ﬁnally inducing mesotheliomas had
been shown to markedly vary in some MWCNTs products, and this
is thought to possibly depend on the differences in the length of
MWCNTs [16,4,12,18]. However, at the present, the differences in
the effects on embryos or fetuses among MWCNTs products with
different sizes remain unclear. The present study was conducted
to clarify the relationship between the sizes of MWCNTs and the
effects on fetuses or dams that result in the fetal toxicity in mice.
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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Table  1
The size, purity and Fe content of the multi-wall carbon nanotubes (MWCNTs) uti-
lized in the present study.
MWCNTs Length (m) Diameter (nm) Purity (%) Fe content (%)
WS  0.5–2 40–70 – 0.046
N  1–4 ; 50.9% 50–80 ; 94.8% >98 0.046
5–20 ; 27.5%
Mean 3.5










































iSD-1 Mean 6 Mean 150 >99.95 <0.005
T  several 10 20–100 85–94 3.822
to several 100
. Materials and methods
. Ethical consideration of the experiment
The experimental protocol was approved by the Experiments
egulation Committee and the Animal Experiment Committee of
he Tokyo Metropolitan Institute of Public Health prior to its execu-
ion. It was monitored at every step during the experimentation for
ts scientiﬁc and ethical appropriateness, which included concern
or animal welfare, with strict obedience to the National Institutes
f Health Guideline for the Care and Use of Laboratory Animals,
he Japanese Government Animal Protection and Management Law,
apanese Government Notiﬁcation on Feeding and Safekeeping of
nimals, and other similar laws, guidelines, rules provided domes-
ically and internationally.
. Test chemicals
The MWCNTs were provided from Mitsui Chemicals Inc., Tokyo
apan (MWNT-7) (M), Nikkiso Co., Ltd. (Tokyo, Japan) (N), Wako
ure Chemicals Industries Ltd. (Osaka, Japan) (WS  and WL), Toda
ogyo Corporation (Hiroshima, Japan) (T) and Showa Denko K. K.,
Tokyo, Japan) (SD-1). The size and purity of each MWCNTs are sum-
arized in Table 1. The MWCNTs were suspended in 2% sodium
arboxymethyl cellulose (Tokyo Chemical Industry Co., Ltd., Tokyo,
apan) /phosphate-buffered saline by vigorous stirring and sonica-
ion for uniform suspension. Those suspensions were autoclaved
120 ◦C, 30 min.) to ensure sterility before use.
. Animals
Speciﬁc pathogen free male and female Crlj: CD1 (ICR) mice
ere purchased from Charles River Laboratories Japan Inc. (Kana-
awa, Japan) and they were housed individually in plastic cages
ith pulp bedding (ALPHA-dri®, Shepherd Specialty Papers, Inc.,
atertown, TN, USA). The animals were allowed free access to the
tandard diet CE2 (CREA Japan, Inc., Tokyo, Japan) and water. The
nimal room was maintained at 23–-25 ◦C with a relative humid-
ty of 50–60%, 10 ventilations per hour (fresh air was  drawn in
hrough a 0.3-m HEPA ﬁlter with 99.9% efﬁciency), and a 12-h
ight/dark cycle. When the mice were 8–12 weeks old, they were
ated by housing one male and one female in cage overnight. The
ext morning, females with vaginal plug were considered at day 0
f gestation.
. ExperimentOn day 9 of gestation, the dams were randomly allocated to
even groups of 10–15 mice each and the groups were admin-
stered a single intraperitoneal dose of MWCNTs (4 mg/10 mL/kgorts 2 (2015) 1404–1408 1405
body weight). This dose has been shown to induce fetal toxic-
ity (fetal death) in the previous teratogenicity study on M [5].
The control mice were administered vehicle. Before and 2 h after
administration, the rectal temperatures of the mice were moni-
tored with an electrical thermometer (Citizen Systems Japan Co.,
Tokyo, Japan). In addition, 2 h after the administration of MWC-
NTs, 6–13 L of peripheral bloods were collected from tail vain by
puncturing it with a needle. Blood smears were prepared from a
part of the collected blood, and the sera from the remaining blood
were stored at −20 ◦C. On day 18 of gestation, the dams were
anesthetized with isoﬂurane, and blood samples were collected in
ethylene diamine tetraacetic acid-2K anticoagulant tubes from the
femoral vein. The white blood cell counts were examined with an
automatic blood analyzer (SYSMEX KX21-NV; SYSMEX Corpora-
tion, Kobe, Japan). Blood smears at 2 h after administration and at
the time of necropsy were stained by Diff-Quik (SYSMEX Corpora-
tion), and the subtypes of white blood cells were counted under
the light microscopy. The livers, spleens, kidneys, thymuses, and
ovaries were weighed. The uteri were opened and the numbers
and positions of implantation site, early dead fetuses (deﬁned as a
case showing the implanted site and amorphous mass), late dead
fetuses (deﬁned as a case showing head and limbs), and live fetuses
were examined. The blood levels of interleukin-6 (IL-6) and mono-
cyte chemoattractant protein-1 (MCP-1) were measured in stored
serum at 2 h after administration with an ELISA Kit (EM2IL6 and
EMMCP1, respectively, Thermo Scientiﬁc Inc., Waltham, MA,  USA).
6. Statistical analysis
Scheffe’s multiple comparisons and the Chi square test were
utilized to analyze the differences between the control and
MWCNT-administered groups.
7. Results
The effects of MWCNTs on general status of dams are shown in
Table 2. In the groups given M,  N, WL,  or SD-1, the rectal temper-
atures 2 h after the administration were signiﬁcantly lower than
that of the control group, while those in the groups given WS  or
T were not signiﬁcantly changed. The percentage of lymphocytes
was decreased and the percentage of neutrocytes was increased 2 h
after the administration in the group given WL,  to compare with
that of the control. Similar tendencies were observed in the other
groups given MWCNTs; however, the changes were not statistically
signiﬁcant. One–three days after the administration, bleeding from
vagina was  noted in the groups given M or N. Two  dams in the group
given SD-1 died at 1 and 3 days, respectively, after the administra-
tion. Necropsies that were performed in those dams cleared the
extensive bleeding in uterine. At day 18 of the gestation, the spleen
weight of the group given M or N were signiﬁcantly increased to
compare with that of the control group, while those of the group
in the groups given WL  or SD-1 were slightly increased and those
given WS  or T were equivalent to the control value. The total white
blood cell counts at the necropsy in the group given M was  signif-
icantly increased, while those in the groups given N or WL  were
slightly increased. The total white blood cell counts in the groups
given WS,  T or SD-1 were similar to or lower than the control value.
The neutrocyte counts in the groups given M or N were signiﬁcantly
higher than that of the control group, while those of the group given
WS,  WL,  T or SD-1 were similar to or lower than the control value.
The eosinocyte counts of the group given M or WL  were signiﬁ-
cantly higher than that of the control group. The monocyte counts in
the group given M was signiﬁcantly higher than that of the control
group.
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Table 2
The effects of intraperitoneal dose of various MWCNTs on the dams.
Control MWCNTs administered (4mg/kg b.w.)
(CMCNa) WS  N M WL  SD-1 T
Female mated 11 10 10 15 10 10 11
Female  died 0 0 0 0 0 2 0
Female  gestated 11 9 9 12 7 8 9
Rectal  temperature
Before the administration 38.4 ± 0.3 38.6 ± 0.2 38.2 ± 0.2 38.1 ± 0.3 38.5 ± 0.3 38.4 ± 0.4 38.5 ± 0.3
2  h after administration 37.4 ± 0.5 36.8 ± 0.7 33.3 ± 0.9** 33.1 ± 0.7*** 34.4 ± 1.2*** 34.8 ± 0.5*** 36.9 ± 0.8
White  blood cell differentiations
2 h after administration
Lymphocyte (%) 64.3 ± 7.1 55.7 ± 10.5 48.9 ± 10.2 48.6 ± 12.3 42.1 ± 6.8* 53.4 ± 13.6 52.6 ± 12.1
Neutrocyte (%) 29.7 ± 6.1 37.0 ± 10.0 44.7 ± 9.2 42.5 ± 11.2 50.3 ± 9.3* 41.2 ± 13.4 40.0 ± 12.8
Eosinocyte (%) 1.3 ± 1.0 2.0 ± 1.4 2.6 ± 1.7 3.0±1.6 2.1 ± 1.5 1.3 ± 1.3 1.9 ± 1.8
Monocyte (%) 4.7 ± 2.4 5.3 ± 1.7 3.9 ± 1.8 5.9 ± 3.0 5.3 ± 3.9 4.1 ± 2.3 5.4 ± 1.4
Organ  weight
Liver (g) 2.86 ± 0.30 3.15 ± 0.35 22.77 ± 0.55 0.94 ± 0.30 2.92 ± 0.70 3.36 ± 0.30 3.21 ± 0.25
Kidney  (mg) 2.86 ± 0.30 464 ± 41 467 ± 85 454 ± 52 460 ± 43 476 ± 34 469 ± 27
Spleen  (mg) 182 ± 36 154 ± 33 474 ± 110*** 360 ± 104*** 246 ± 34 476 ± 34 169 ± 36
Thymus (mg) 24.7 ± 7.2 29.3 ± 8.8 37.2 ± 9.3 25.8 ± 7.8 25.5 ± 6.0 26.4 ± 9.0 26.5 ± 7.9
Adrenals (mg) 9.1 ± 1.4 9.7 ± 1.5 10.3 ± 1.9 10.4 ± 1.2 9.6 ± 0.5 26.4 ± 9.0 10.0 ± 1.6
Ovaries  (mg) 19.0 ± 2.6 24.7 ± 4.2 29.8 ± 2.4 5.0 ± 4.4 123.6 ± 4.3 26.3 ± 2.4 26.5 ± 3.2
White  blood cell count (x102/L)
Total 62.7 ± 13.4 48.4 ± 20.9 82.1 ± 15.7 108.9 ± 37.0** 76.3 ± 13.5 76.3 ± 13.5 76.3 ± 13.5
Lymphocyte 29.2 ± 8.7 26.4 ± 10.7 218.5 ± 4.6 7.9 ± 8.7 27.9 ± 3.5 23.9 ± 6.6 24.5 ± 9.2
Lymphocyte 28.3 ± 10.3 19.8 ± 13.6 47.0 ± 8.9* 48.8 ± 19.6* 27.9 ± 3.5 24.0 ± 5.0 18.9 ± 8.2























sEosinocyte 3.7 ± 2.0 0.7 ± 0.6 6.6 ±
alues are the means ± standard deviations for numbers of the dam in each group. 
ontrol  values (*, ** or *** indicating p < 0.05, 0.01 or 0.001, respectively).
Effects of MWCNTs on the pregnant status of dams are shown
n Table 3. The number of early dead fetus and the percentage of
he early dead fetus in the implantation were signiﬁcantly higher
n the groups given M than those of the control group. In the group
iven N, the number of dam with one more live fetus was zero,
nd the number of early dead fetus was equal to the number of the
mplantation, which resulted in 100% of the early dead fetus in the
mplantation. In the groups given WL  or SD-1, the number of early
ead fetus had a tendency to be increased, but these differences
ere not statistically signiﬁcant. The incidence of the dam with
arly dead fetus in the groups given M,  N, WL,  T or SD-1, was  sig-
iﬁcantly higher than that of the control. The number of late dead
etus or the percentages of late dead fetus in the implantation was
ot changed in any of the groups given MWCNTs. Resulting from
ncreased number of the dead fetus in early stage, the number of
ive fetus and the percentage of live fetus in the implantation in the
roup given M were signiﬁcantly lower than those of the control
able 3
he effects of intraperitoneal dose of various MWCNTs on pregnancy status.
Reproductive parameters Control MWCNTs administered (4 mg/k
(CMCNa) WS  N 
Female gestated 11 9 9 
Female with>1 live fetus 11 9 0*** 
Implantations/littera 13.3 ± 2.4 14.6 ± 2.2 14.6 ± 1.8 
Number of earlybdead fetusa 0.1 ± 0.3 0.4 ± 0.5 14.6 ± 1.8**
(%  of implantations) 1 ± 2 3 ± 4 100 ± 0*** 
Female  with early dead fetus 1 4 9*** 
Number of latebdead fetusa 0.3 ± 0.5 0.2 ± 0.4 0 
(%  of implantations) 2 ± 4 1 ± 3 0 
Female  with late dead fetus 2 2 2 
Live  fetus/littera 12.9 ± 2.5 13.9 ± 2.2 0*** 
97  ± 4 95 ± 4 0*** 
Body  weight of live fetus (g)a
Male 1.398 ± 0.14 1.367 ± 0.137 — 
Female  1.352 ± 0.111 1.316 ± 0.142 — 
he percent resorption (early or late dead fetus) and fetal body weight were obtained 
igniﬁcantly different from the corresponding control values (*, ** or *** indicating p < 0.0
a Values are the means ± standard deviations.
b ‘Early’ was  deﬁned as a case showing the implanted sites and amorphous mass, while10.0 ± 6.7* 5.0 ± 1.8 3.4 ± 1.5 2.4 ± 2.2
terisks represent that the values are signiﬁcantly different from the corresponding
group. And the number of live fetus and the percentage of live fetus
in the implantation in the group given N were zero. The body weight
of live fetus (male and female) was  not changed in the groups given
MWCNTs.
Blood levels of IL-6 and MCP-1 in the dams 2 h after administra-
tion of MWCNTs are shown in Fig. 1. In the groups given M or N,
signiﬁcant increases in the blood levels of both IL-6 and MCP-1 were
found. In the groups given WL  or SD-1, those cytokine levels were
somewhat increased, but these differences were not statistically
signiﬁcant to compare with those of the control.
8. DiscussionThe fetal toxicity of MWCNTs markedly varied among the prod-
ucts tested. Administration of M (main length 5–20 m)  and N
(main length 1–20 m)  signiﬁcantly decreased the number of live
fetuses. Administration of WL (length 0.5–10 m)  and SD-1 (mean
g b.w.)
M WL  SD-1 T
12 7 8 9
8 6 8 9
14.5 ± 1.6 13.6 ± 3.3 16.8 ± 1.7 15.4 ± 2.4
* 8.8 ± 6.3*** 3.6 ± 5.2 3.8 ± 2.9 0.9 ± 0.8
59 ± 41*** 24 ± 35 10 ± 9 6 ± 5
10*** 6** 7** 6*
0.3 ± 0.6 0.1 ± 0.4 0.4 ± 0.5 0.3 ± 0.5
2 ± 4 1 ± 3 2 ± 3 2 ± 3
0 1 3 3
5.5 ± 5.6** 10.0 ± 5.1 12.6 ± 3.9 14.2 ± 2.0
39 ± 40*** 76 ± 35 88 ± 6 92 ± 7
1.360 ± 0.146 1.320 ± 0.125 1.340 ± 0.123 1.435 ± 0.058
1.228 ± 0.068 1.306 ± 0.034 1.252 ± 0.140 1.376 ± 0.073
by averaging the value for each litter. The asterisks represent that the values are
5, 0.01 or 0.001, respectively).
 ‘Late’ was deﬁned as a case showing the head and limbs.














Fig. 1. Blood cytokine levels in dam 2 h after administration of multi-wall carbon















































Nion  for numbers of the dam in the groups given MWCNTs or the control group. The
sterisks represent that the values are signiﬁcantly different from the corresponding
ontrol values (** or *** indicating p < 0.01 or 0.001, respectively).
ength 6 m)  resulted in slight but non-signiﬁcant increase in fetal
oss. Administration of WS  (length 0.5–2 m)  and T (length several
0 to several 100 m)  did not decrease the number of live fetuses
n dam but the incidence of dam with early fetal death in T was sig-
iﬁcant from that of the control group. These results indicated that
 moderate length of MWCNTs (those that are not short and not
ong), such as 5–20 m,  may  be necessary to induce fetal toxicity
n mice. It had been concerned that the oxidative stress by catalytic
ction of Fe contained in the MWCNTs may  be possibly the mecha-
istic pathogenesis in mesothelioma induction [14]. However, the
ame theory can’t be adaptive to the fetal toxicity, because T that
ad the second high Fe content in the presently utilized MWCNTs
ad the minimum fetal toxicity and N that had the same Fe con-
ent as WS  had marked fetal toxicity to compare with WS  with
o fetal toxicity in the present study. Also, it was likely that the
iameter of MWCNTs had no important relation on the fetal toxi-
ity, because WS  with diameter of 40–70 nm had no fetal toxicity
o compare with N and M with diameter of 50–80 nm. It may  be
ossible, however, that the high diameter reduces the fetal toxic-
ty, because WL  and SD-1 with relatively high diameter than N or
 appeared slight and non-signiﬁcant fetal effects in the present
tudy. These results in the present study on fetal toxicity did not
ave contradiction to the report by Nagai [13] in which thin MWC-
Ts (diameter −50 nm)  showed cytotoxicity and inﬂammogenicity
han thick MWCNTs (diameter −150 nm). Also, it was  shown that
he fetal toxicity of MWCNTs did not depend on the particular man-
facturer, because both WS  with no fetal toxicity and WL  with slight
signiﬁcant incidence of dam with early fetal death) fetal toxicity
ere provided by the same manufacturer.
We conducted the experiment of administration in intraperi-
oneal cavity to avoid the stress to the dam such as anesthetizing
nd intratracheal administration, because the previous study [5]
ndicated that intraperitoneal administration of MWCNTs had
qual effects on fetus to that of intratracheal administration. It had
e shown that intraperitoneally administered asbestos ﬁbers were
ngulfed in phagocytes Winkler and Rüttner, 1982 and we observed
he grayish-colored and swollen lymph nodes beside the thymus
n the thoracic cavity of dams given MWCNTs or asbestos, in the
revious studies [12,13] and the present study (data not shown),
ndicating that those ﬁbrous materials might be carried by lym-
hatic or blood ﬂow from peritoneal cavity. As the asbestos ﬁbers
ad been provided on the transplacental distribution form dam
o fetus in human and experimental animals (Haque et al., 2001)
3,7–9], the same route to fetus might be speculated in the MWC-
Ts. However, the existence of MWCNTs in fetus has yet not provedorts 2 (2015) 1404–1408 1407
at present. And it is unclear whether the cytotoxicity, the oxidative
stress and the genotoxicity of single wall carbon nanotubes [23] or
MWCNTs [1] observed in the cultured cell lines can be applied on
the mechanism of the case of fetal toxicity in mice.
In the present study with intraperitoneal administration and the
previous study with intraperitoneal and intratracheal administra-
tion [5], we  observed the increase of the white blood cell counts,
particularly those of the neutrocytes and eosinocyte, and signiﬁ-
cant increase of spleen weight in the groups given MWCNTs on
day 18 of gestation, which indicated the presence of inﬂammatory
change(s) in dams given MWCNTs. Because pregnancy depends
upon the highly delicate and successful balance of immunological
status, which exceptionally allows growing of the genetically dif-
ferent organism in dam, it is likely that perturbation in the balance
of immunological status results in discontinuance of pregnancy, so-
called rejection of fetus [15,24,11]. Yamaguchi et al. [22] reported
the detailed inﬂammatory response after intraperitoneal admin-
istration of MWCNTs in female mice. However, those previous
observation on inﬂammatory changes were at more than 1 week
after [22] or at 9 days after (day 18 of the gestation) [5] administra-
tion of MWCNTs. As was clearly shown in the present study and the
previous study [5], fetal loss induced by administration of MWCNTs
depended on an increase of early fetal death, and not on the late
fetal death. The inﬂammatory changes that occurred at early stage
after administration of MWCNTs might be more important in the
fetal toxicity that induced by MWCNTs than those that occurred at
late stage of gestation. In addition, in the preliminary experiment,
we observed the changes in the white blood cell differentiations in
pregnant mice that occurred after administration of MWCNTs dif-
fered from those in non-pregnant females, in which the increase of
eosinocyte counts was numerous than the increase of neutrocyte
counts. The inﬂammatory response to MWCNTs in the pregnant
female appeared to be different from the non-pregnant female or
male mice. Thus, in the present study, we made observation on
the white blood cell differentiations and analyzed the cytokine
change(s) in dam soon after administration of MWCNTs, in conjunc-
tion with the comparison of fetal toxicity of MWCNTs with various
sizes. In the white blood cell differentiations, percentages of neu-
trocytes were increased in the most groups given MWCNTs 2 h after
their administration as well as at the necropsy. Regrettably, blood
samples gained 2 h after administration were not enough (50 L)
to analyze total white blood cell counts. However, the tendencies
to increase neutrocytes and eosinocytes was similar to the white
blood cell differentiations at necropsy, in which case, increased
white blood cell counts depended on the increases of neutrocyte
counts and eosinocyte counts. It is probable that the total white
blood cell counts 2 h after the administration of MWCNTs might
increase as a result of the increase of neutrocytes and eosinocytes.
These inﬂammatory changes that occurred soon after administra-
tion of MWCNTs in dams could affect fetuses. We thought that
a more detailed analysis on the inﬂammatory changes in dam,
for example, cytokine and/or chemokine measurement might be
necessary, because the administration of IL-2 caused the abortion
in mice [20]. In the preliminary experiment, serum levels of IL-6
and MCP-1 signiﬁcantly increased soon after the administration of
MWCNTs (M)  in pregnant females, while serum levels of IL-1, IL-2,
IL-4, IL-8, IL-10, IL-12 (total), the tumor necrosis factor alpha (TNF)
and the interferon gamma (IFN) were not signiﬁcantly changed
(data not shown). It was  likely that IL-6 and MCP-1 levels in dam are
important in the effect(s) of the MWCNTs on the fetuses. The result
of the present study induced that (1) the MWCNTs (M and N) that
caused marked fetal death also resulted in signiﬁcantly increase
in the level of IL-6 and MCP-1 in the dams, (2) the MWCNTs (WL
and SD-1) that caused less fetal death resulted in slight increase in
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id not affects live fetus numbers caused only negligible changes
n those cytokines, supported the fore mentioned hypothesis.
In addition to the inﬂammatory changes, dam given MWCNTs
M)  appeared remarkably less active from several hours to 1 day
fter administration in the previous study. Regrettably we  were
nable to measure blood pressure of mice, for the next best thing,
e measured the rectal temperature of dams 2 h after administra-
ion with comparing that at immediately before the administration
f MWCNTs. The MWCNTs (M and N) that caused marked fetal
eath also signiﬁcantly lowered the rectal temperatures of dams,
he MWCNTs (WL  and SD-1) that caused mild fetal death slightly
owered the rectal temperatures and the MWCNTs (WS  and T) that
id not affects live fetus numbers caused only negligible changes
n the rectal temperatures. Although main organ weights, except
pleen, did not change, indicating less toxicity on dams by MWC-
Ts, something shock-like status by the administration of effective
WCNTs on fetus was suggested. The mechanism that caused this
ondition is currently unclear. Also, the relationship or the eventual
rder in the inﬂammatory change, the shock-like status and fetal
eath is not clear. A study to clarify the relationship between these
hanges and the fetal loss that induced by MWCNTs is now being
onduction in our laboratory.
. Conclusion
MWCNTs of mean length(m)  1–20 and 5–20 showed severe
etal toxicity and those of length 0.5–10 and mean length 6 had
ild fetal toxicity, while those of length under 2 and over several
ens had negrigible fetal toxicity in mice. Diameter, purity or Fe
ontent of MWCNTs seemed not related to the fetal toxicity. In dams
iven effective MWCNTs, white blood cell counts, spleen weight
nd blood levels of IL-6 and MCP-1 were increased. A relationship
etween inﬂammation in the dam, which probabely depended on
he length of the MWCNTs, and the fetal toxicioty of MWCNTs in
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